US Broker Ratings

Disc Medicine, Inc. (IRON) Stock Analysis: A 20% Upside Potential in the Biotech Sector

Disc Medicine, Inc. (NASDAQ: IRON), a dynamic player in the biotechnology sector, has caught the attention of investors with its robust product pipeline and promising financial outlook. Headquartered in Watertown,..

Evotec SE (EVO) Stock Analysis: Navigating a Potential 32.76% Upside in the Healthcare Sector

Evotec SE (EVO), a prominent player in the healthcare sector, is currently drawing significant attention from investors keen on its potential upside. With its stock price hovering at $4.12 USD..

Evolent Health, Inc (EVH) Stock Analysis: A 102% Potential Upside Amidst Healthcare Sector Challenges

Evolent Health, Inc. (NYSE: EVH) is a compelling player within the healthcare sector, specifically in the niche of health information services. With a market capitalization of $886.02 million, Evolent Health..

Novavax, Inc. (NVAX) Stock Analysis: Unpacking a 51.85% Upside Potential and the Road Ahead

Novavax, Inc. (NASDAQ: NVAX) is a name that continues to draw considerable attention within the biotechnology sector, particularly for investors eyeing significant potential upside. With a market capitalization of $1.41..

Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: A Closer Look at the 21.95% Potential Upside

Amneal Pharmaceuticals, Inc. (AMRX), a global biopharmaceutical company, has been capturing investor attention, not only for its diverse range of pharmaceutical products but also for its significant potential upside. Currently..

Viridian Therapeutics, Inc. (VRDN) Stock Analysis: Exploring a 69.70% Potential Upside in the Biotechnology Sector

Viridian Therapeutics, Inc. (VRDN), a prominent player in the biotechnology sector, has been making waves with its innovative approach to developing treatments for serious and rare diseases. With a current..

Opko Health, Inc. (OPK): Analyst Ratings Shine with 150% Potential Upside Amidst Current Challenges

Opko Health, Inc. (OPK), a prominent player in the healthcare sector, is drawing significant attention from investors, especially with its analyst ratings projecting a striking 150% potential upside. Despite facing..

CONMED Corporation (CNMD) Stock Analysis: Unveiling a 28.8% Potential Upside in the Medical Device Sector

CONMED Corporation (NASDAQ: CNMD), a distinguished player in the medical devices industry, presents an intriguing opportunity for investors with its substantial 28.8% potential upside. Headquartered in Largo, Florida, and boasting..

Schrodinger, Inc. (SDGR): Analyst Ratings Reveal a 21.79% Upside Potential

Investors looking to capitalize on innovation in healthcare technology should take a closer look at Schrodinger, Inc. (NASDAQ: SDGR). With a market capitalization of $1.63 billion, this New York-based company..

U.S. Physical Therapy, Inc. (USPH) Investor Outlook: Exploring a 17.58% Potential Upside

Savvy investors seeking promising opportunities in the healthcare sector should take a closer look at U.S. Physical Therapy, Inc. (NYSE: USPH). With its solid footing in the medical care facilities..

BioLife Solutions, Inc. (BLFS) Stock Analysis: A 12.34% Upside Potential in the Booming Cell and Gene Therapy Market

BioLife Solutions, Inc. (NASDAQ: BLFS) is a name that continues to attract attention in the healthcare sector, particularly within the niche of medical instruments and supplies. With a market cap..

Arcutis Biotherapeutics, Inc. (ARQT)

⚠️ No article content returned.

..

LifeStance Health Group, Inc. (LFST) Stock Analysis: Exploring a 63% Potential Upside for Investors

LifeStance Health Group, Inc. (NASDAQ: LFST) is a prominent player in the healthcare sector, specifically within the medical care facilities industry, focusing on providing outpatient mental health services across the..

Ultragenyx Pharmaceutical Inc. (RARE): Investor Outlook with 143% Potential Upside

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) is capturing the attention of investors, especially those with an appetite for the dynamic and transformative biotech sector. With a market capitalization of $3.4 billion,..

Zai Lab Limited (ZLAB) Stock Analysis: A Biotech Contender with 109% Upside Potential

Zai Lab Limited (NASDAQ: ZLAB), the Chinese biopharmaceutical powerhouse, is making waves in the biotechnology sector with a robust portfolio of products and strategic collaborations. With a market capitalization of..

Agios Pharmaceuticals (AGIO) Investor Outlook: Analyzing the 8.33% Potential Upside

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) is making waves in the biotechnology industry, thanks to its innovative approach to cellular metabolism and its promising pipeline of therapeutics. With a robust market..

Catalyst Pharmaceuticals, Inc. (CPRX) Stock Analysis: Exploring a Potential 60% Upside

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX), a prominent player in the biotechnology sector, is capturing investor attention with a potential upside of 60.29%. With a market capitalization of $2.62 billion, this..

Mineralys Therapeutics, Inc. (MLYS) Stock Analysis: Exploring a 7.86% Upside Potential in Biotechnology

Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a clinical-stage biopharmaceutical company, has been gaining attention in the biotechnology sector for its innovative approach to tackling diseases driven by dysregulated aldosterone. With a..

Veracyte, Inc. (VCYT) Stock Analysis: Navigating a 14.26% Potential Upside in the Diagnostics Sector

Veracyte, Inc. (NASDAQ: VCYT) is an intriguing player in the healthcare sector, operating within the diagnostics and research industry. With a market capitalization of $2.83 billion, Veracyte is renowned for..

Astrana Health Inc. (ASTH) Stock Analysis: Exploring a 36% Upside Potential

Astrana Health Inc. (NASDAQ: ASTH), a prominent player in the healthcare management sector, has been capturing investor attention due to its robust growth metrics and potential upside. With a market..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds